BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
17.44
-0.62 (-3.43%)
At close: Apr 28, 2026, 4:00 PM EDT
17.17
-0.27 (-1.55%)
Pre-market: Apr 29, 2026, 7:00 AM EDT
BioAge Labs Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Cash & Equivalents | 188.89 | 354.35 | 21.64 | 27.64 |
| Short-Term Investments | 92.21 | - | - | - |
| Cash & Short-Term Investments | 281.1 | 354.35 | 21.64 | 27.64 |
| Cash Growth | -20.67% | 1537.17% | -21.70% | - |
| Accounts Receivable | 0.77 | - | - | - |
| Other Receivables | 1.2 | 1.2 | - | - |
| Receivables | 1.97 | 1.2 | - | - |
| Prepaid Expenses | 3.73 | 1.55 | 0.35 | 0.39 |
| Restricted Cash | - | - | 3.31 | - |
| Total Current Assets | 286.79 | 357.1 | 25.31 | 28.03 |
| Property, Plant & Equipment | 3.75 | 0.79 | 0.52 | 0.37 |
| Long-Term Investments | 4.13 | 0.1 | 0.1 | - |
| Other Long-Term Assets | 0.22 | 0.24 | - | 0.03 |
| Accounts Payable | 2.67 | 2 | 1.87 | 2.26 |
| Accrued Expenses | 7.96 | 11.33 | 6.55 | 3.36 |
| Short-Term Debt | - | - | 38.86 | - |
| Current Portion of Long-Term Debt | 2.65 | 6 | 6 | 0.17 |
| Current Portion of Leases | 0.58 | 0.2 | 0.19 | 0.05 |
| Current Unearned Revenue | 5.75 | 7.83 | 3.31 | - |
| Other Current Liabilities | 0.53 | 0.42 | 1.39 | 0.02 |
| Total Current Liabilities | 20.14 | 27.78 | 58.17 | 5.86 |
| Long-Term Debt | - | 2.5 | 8.2 | 2.25 |
| Long-Term Leases | 2.33 | - | - | - |
| Long-Term Unearned Revenue | - | 4.67 | - | - |
| Other Long-Term Liabilities | 0.37 | 0.16 | 0.23 | 0.15 |
| Additional Paid-In Capital | 605.19 | 575.69 | 8.14 | 5.12 |
| Retained Earnings | -333.42 | -252.81 | -181.7 | -117.85 |
| Comprehensive Income & Other | 0.28 | 0.25 | 0.16 | 0.17 |
| Total Common Equity | 272.05 | 323.13 | -173.4 | -112.56 |
| Total Liabilities & Equity | 294.89 | 358.23 | 25.92 | 28.43 |
| Total Debt | 5.56 | 8.7 | 53.25 | 2.47 |
| Net Cash (Debt) | 279.57 | 345.65 | -31.61 | 25.18 |
| Net Cash Growth | -19.12% | - | - | - |
| Net Cash Per Share | 7.78 | 32.22 | -18.90 | 15.06 |
| Filing Date Shares Outstanding | 44.38 | 35.85 | 1.67 | 1.67 |
| Total Common Shares Outstanding | 37.39 | 35.85 | 1.67 | 1.67 |
| Working Capital | 266.66 | 329.33 | -32.86 | 22.17 |
| Book Value Per Share | 7.28 | 9.01 | -103.62 | -67.33 |
| Tangible Book Value | 272.05 | 323.13 | -173.4 | -112.56 |
| Tangible Book Value Per Share | 7.28 | 9.01 | -103.62 | -67.33 |
| Machinery | 1.26 | 0.79 | 0.74 | 0.58 |
| Construction In Progress | 0.02 | 0.18 | - | - |
| Leasehold Improvements | 0.16 | - | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.